SkinHealth Systems (SKIN) Financial statements
SkinHealth Systems reported revenue of $301M in fiscal 2025, up 10.3% a year over 6 years.
Key figures
Net income was -$10M and the operating margin -6.9%, against 8.1% in 2019. Free cash flow was $37M. The diluted share count rose 323% over the period (dilution).
- Revenue, FY2025
- $301M-10.0% on 2024
- Net income
- -$10M-67.3% on 2024
- Operating margin
- -6.9%
- Free cash flow
- $37M+141.8% on 2024
Revenue and free cash flow
Fiscal years, from SkinHealth Systems's 10-K filings.
SkinHealth Systems revenue and free cash flow
FY2019–FY2025Margins
How much of each dollar of revenue is left after the cost of sales, after operating costs, and at the bottom line.
SkinHealth Systems margins
FY2019–FY2025Financial statements
Fiscal 2019–2025.
SkinHealth Systems income statement, fiscal 2019–2025
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $167M | $119M | $260M | $366M | $398M | $334M | $301M |
| Cost of revenue | $60M | $52M | $82M | $117M | $243M | $152M | $104M |
| Gross profit | $107M | $67M | $179M | $249M | $155M | $182M | $196M |
| Research and development | $5M | $3M | $8M | $8M | $10M | $6M | $6M |
| Selling, general and admin | $88M | $81M | $210M | $266M | $276M | $244M | $212M |
| Operating income | $13M | -$17M | -$40M | -$26M | -$131M | -$68M | -$21M |
| Interest expense | $17M | $21M | $12M | $13M | $14M | $10M | $19M |
| Pre-tax income | -$3M | -$38M | -$381M | $45M | -$102M | -$30M | -$6M |
| Income tax | -$1M | -$9M | -$2M | $1M | -$2M | -$452,000 | $4M |
| Net income | -$2M | -$29M | -$379M | $44M | -$100M | -$29M | -$10M |
| EPS (diluted) | -$1.00 | -$17.00 | -$74.20 | -$4.60 | -$15.20 | -$7.20 | -$3.20 |
| Diluted shares | 2M | 2M | 5M | 7M | 7M | 7M | 7M |
| Gross margin | 63.9% | 56.4% | 68.6% | 68.0% | 39.0% | 54.5% | 65.3% |
| Operating margin | 8.1% | -14.4% | -15.4% | -7.1% | -32.9% | -20.3% | -6.9% |
| Net margin | -1.0% | -24.5% | -145.6% | 12.1% | -25.2% | -8.7% | -3.2% |
SkinHealth Systems balance sheet, fiscal 2019–2025
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $7M | $9M | $902M | $568M | $523M | $370M | $233M |
| Receivables | — | $19M | $47M | $76M | $55M | $28M | $22M |
| Inventory | — | $23M | $35M | $110M | $91M | $69M | $48M |
| Total current assets | — | $59M | $1.0B | $783M | $698M | $477M | $310M |
| Property, plant and equipment | — | $9M | $16M | $18M | $14M | $6M | $3M |
| Goodwill | $99M | $99M | $124M | $125M | $126M | $123M | $127M |
| Total assets | — | $223M | $1.2B | $1.0B | $929M | $686M | $500M |
| Total current liabilities | — | $31M | $76M | $72M | $115M | $68M | $186M |
| Long-term debt | — | $0 | $730M | $734M | $738M | $552M | $240M |
| Total liabilities | — | $253M | $917M | $836M | $870M | $634M | $439M |
| Shareholders' equity | -$1M | -$31M | $298M | $167M | $59M | $52M | $61M |
| Net debt | -$7M | -$9M | -$172M | $166M | $215M | $182M | $132M |
SkinHealth Systems cash flow, fiscal 2019–2025
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $2M | -$12M | -$28M | -$107M | $22M | $16M | $37M |
| Capital spending | $9M | $4M | $11M | $11M | $4M | $756,000 | $303,000 |
| Free cash flow | -$7M | -$16M | -$40M | -$117M | $18M | $15M | $37M |
| Stock-based compensation | $103,000 | $363,000 | $12M | $28M | $23M | $27M | $15M |
| Share buybacks (net) | $0 | -$154,000 | $0 | -$160M | -$30M | $0 | $0 |
| Free cash flow margin | -4.2% | -13.4% | -15.2% | -32.1% | 4.5% | 4.6% | 12.4% |
How SkinHealth Systems compares
SkinHealth Systems's operating margin is higher than 30% of Consumer Defensive companies and 33% of the 2,820 companies with an operating margin figure.
| Higher than | Consumer Defensive | All stocks |
|---|---|---|
| Operating margin | 30% | 33% |
| Net margin | 9% | 20% |
| Gross margin | 90% | 78% |
| Revenue growth | 13% | 14% |
| ROE | 4% | 13% |
Questions about SkinHealth Systems
What was SkinHealth Systems's revenue in 2025?
$301M in fiscal 2025, from its 10-K filing.
How much free cash flow does SkinHealth Systems generate?
$37M in fiscal 2025 (operating cash flow minus capital spending).
From SkinHealth Systems's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.